Executive Search Success Story: Placing a VP of Operations to Turn Around Compliance and Supply Reliability for a Sterile Injectables Manufacturer

How JRG Partners executed a confidential North American executive search that equipped a private-equity-backed sterile injectables manufacturer with the VP of Operations and site leadership required to resolve regulatory observations, restore supply reliability to hospital and distributor customers, and rebuild a culture of compliance and operational discipline across two aseptic manufacturing sites.

The Challenge

A private-equity-backed sterile injectables manufacturer supplying hospitals and national distributors from two aseptic sites had received significant FDA observations at its primary facility, citing deficiencies in aseptic practices, environmental monitoring, and deviation management. Batch rejections and release delays had driven product shortages, hospital customers were sourcing from competitors, and the sponsor’s value-creation plan was at risk. The operations leader had been removed, and the two sites operated with different practices and cultures. Executive leadership identified several critical vulnerabilities threatening the business:

• FDA Form 483 observations at the primary site with the risk of escalated enforcement
• Batch rejection rates exceeding 12% driving product shortages and lost hospital accounts
• Release cycle times more than double industry benchmarks due to deviation backlogs
• Aseptic practices, environmental monitoring, and training inconsistent across the two sites
• No operational excellence or manufacturing compliance function
• Operations leadership vacancy during an active regulatory response

Recognizing that the remediation and turnaround required an experienced sterile manufacturing executive, the CEO and sponsor engaged JRG Partners for an expedited search for a VP of Operations, supported by a Site Head for the primary aseptic facility and a Director of Manufacturing Compliance & Operational Excellence. The company required an executive search partner with deep sterile pharma expertise and immediate access to operations leaders who had led aseptic remediation and supply recovery.

Why They Chose JRG Partners

Sterile and Pharmaceutical Manufacturing Expertise

JRG Partners possesses deep recruiting expertise across sterile injectable manufacturers, generic and specialty pharma, and aseptic CDMOs, including operations, site leadership, and manufacturing compliance. This domain knowledge ensured an immediate understanding of aseptic processing, regulatory remediation, and supply recovery dynamics.

Regulatory Turnaround Experience

Our team specializes in identifying operations leaders who have resolved FDA observations in sterile facilities, rebuilt compliance cultures, and restored supply reliability under regulatory and customer pressure.

Speed Under Regulatory and Customer Pressure

JRG Partners structured the engagement to deliver qualified finalists within two weeks, recognizing that the regulatory response and product shortages required leadership in place immediately.

Our Executive Search Strategy

Phase 1 — Compliance & Operations Review

Our consultants partnered directly with the CEO, sponsor operating partners, head of quality, and outside regulatory counsel to assess the FDA observations, batch rejection drivers, release backlogs, and site cultures. This review defined a VP of Operations profile combining aseptic remediation leadership and multi-site operational turnaround.

Phase 2 — Talent Identification & Mapping

Our research team performed an extensive talent mapping initiative targeting operations leaders at sterile injectable manufacturers, specialty pharma, and aseptic CDMOs who had led documented regulatory remediations and supply recoveries. Over 290 executives were systematically assessed across these sectors.

Phase 3 — Candidate Engagement

Priority during outreach was given to leaders with a documented history of closing FDA observations in aseptic facilities, reducing batch rejection rates, clearing deviation backlogs, standardizing aseptic practices across sites, and restoring customer supply. Only candidates meeting these strict performance baselines advanced.

Phase 4 — Selection Process

Finalists presented a remediation and supply recovery plan to the CEO, sponsor, and quality leadership, completed structured leadership assessments, and underwent reference verification focused on quantified compliance, rejection rate, and supply outcomes.

Key Outcomes

• 290+ sterile and pharmaceutical manufacturing operations leader profiles mapped across North America.
• Placed a VP of Operations with proven aseptic remediation experience in 44 days during an active regulatory response.
• Closed all FDA observations with a clean follow-up inspection.
• Reduced batch rejection rates from over 12% to under 2%.
• Eliminated product shortages and recovered lost hospital accounts.
• Standardized aseptic practices and compliance culture across two manufacturing sites.